Liminal BioSciences Inc reports results for the quarter ended in June - Earnings Summary

Liminal BioSciences

16/08/2021 22:39

* Liminal BioSciences Inc  LMNL.OQ  reported a quarterly
adjusted loss of C$1.07​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of 53 cents per share.
* Revenue was C$250.00 thousand​;  analysts expected C$226.00
thousand. 
* Liminal BioSciences Inc's reported EPS for the quarter was a
loss of C$1.07​.
* The mean earnings estimate of analysts had risen by about 3.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Liminal BioSciences Inc shares had fallen by 33.2% this
quarter and lost 38.1% so far this year.
* The company reported a quarterly loss of C$32.04 million.
* Wall Street's median 12-month price target for Liminal
BioSciences Inc is $4.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 16 at 09:39 p.m.  ​All
figures in Canadian dollars unless otherwise stated